Sterile filling and freeze-drying vaccine facility
MSD is boosting vaccine production to meet growing worldwide demand
Background to this project
MSD is a leading global biopharmaceutical manufacturer and the largest pharmaceutical company in the Netherlands. The company is substantially expanding its vaccine manufacturing capacity to meet the growing worldwide demand.
State-of-the-art vaccines facility
This new brownfield development at MSD’s existing Boxmeer site incorporates advanced technology to provide additional production capacity for sterile filling and freeze drying of vaccines. The facility also incorporates a utilities building and associated infrastructure, with capacity for future expansion.
PM Group’s services on the project included full project lifecycle design, procurement, construction and CQV.
Watch this short video of the SFFD facility in operation:
Time
1m
safe hours worked on site
People
450
people on site at peak of construction
Challenges
500,000
of these safe hours were worked under Covid 19 restrictions
Collaboration for safety performance
At peak construction, over 450 people entered the project site daily. The workforce came from over 25 countries including Iran, Iraq, Kazakhstan, North Africa and Europe.
With such a broad cultural workforce, managing a safe site posed many obstacles. However the main project contractors from the Netherlands, Ireland, Belgium, Germany, Austria and Slovenia overcame the challenges with their strong commitment to and collaboration for safety.
“Paramount to the successful safety record achieved on this project was the commitment and leadership by PM Group’s design, construction management and CQV teams.”
Rory Kelly
Project Manager
Contact Us
Thank you for your enquiry. We will be in touch presently.
In the meantime you may find this content relevant to your interests.
